eMedicine Specialties > Ophthalmology > Infectious Disease

Lyme Disease

Author: Gerald W Zaidman, MD, Professor of Clinical Ophthalmology, New York Medical College; Chief of Cornea Service, Acting Director, Department of Ophthalmology, Westchester Medical Center
Contributor Information and Disclosures

Updated: Jul 25, 2008

Introduction

Background

Lyme disease is the most common arthropod-related disease in the United States, Europe, and portions of Japan.

Lyme disease is transmitted by the bite of an Ixodes tick infected with Borrelia burgdorferi. Ehrlichiosis and babesiosis are also transmitted by the Ixodes tick. The disease is a multisystem spirochetal disorder that can mimic many other diseases. As in syphilis, another spirochetal illness, Lyme disease occurs in 3 stages.

The life cycle of the Ixodes tick consists of 3 stages, as follows: larval, nymphal, and adult. Mice and deer are most commonly involved in this cycle, but any mammal can serve as the tick's host. The nymphal stage is the most aggressive. Ticks in this stage feed in mid to late spring. Because of their extremely small size, many people do not remember the tick bite.

Pathophysiology

The pathogenesis of Lyme disease is not well understood, but the symptoms are believed to be due to direct infection and a delayed hypersensitivity mechanism. A controversial aspect of the disease is the form of the disease known as late or chronic Lyme disease. Some patients may develop chronic or relapsing inflammation (including uveitis). It is unknown if these patients truly have Lyme disease and if they represent treatment failures, a persistence of organism, an infection with another tick borne pathogen, or an autoimmune phenomenon.

Frequency

United States

Of the cases of Lyme disease, 75% occur during the summer months. Clusters of Lyme disease occur in 3 geographic areas of the United States, as follows: the Northeast, especially in southern Connecticut, WestchesterCounty, and Long Island in the state of New York; the Midwest, in Minnesota and Wisconsin; and the Northwest, in Washington, Oregon, and northern California.

Race

No racial predilection exists.

Sex

No sexual predilection exists.

Age

With Lyme disease, there is a bimodal distribution of age groups with 2 peaks, one in children aged 5-14 years and one in adults aged 30-59 years.

Clinical

History

  • The clinical manifestations of untreated Lyme disease occur in 3 stages.
    • Stage 1 is the localized bull's eye skin rash of erythema chronicum migrans. This pathognomonic skin rash begins 3-30 days after the tick bite; however, as many as 18% of patients can present without the skin rash.
    • Stage 2 follows weeks to months later. These patients may develop neurologic (15%), cardiac (5%), or arthritic (60%) manifestations. Neurologic signs can include cranial neuropathy (especially Bell palsy), meningitis, headache, or neuritis. 
    • In stage 3, the most common manifestation is chronic Lyme arthritis. Chronic neurologic syndromes include neuropsychiatric disease and peripheral neuropathy.

Physical

  • Ocular manifestations of Lyme disease may involve any portion of the eye and vary depending on the stage of the disease.
    • In stage 1 Lyme disease, the ocular manifestations are conjunctivitis and photophobia. These symptoms are mild and transient, and ophthalmologists usually are not consulted.
    • During stage 2 Lyme disease, significant ophthalmic complications first appear. The most common are various neuro-ophthalmologic signs. Typically, the patient may first present with cranial nerve VII palsy (Bell palsy). Some patients may present with the triad of Lyme neuroborreliosis consisting of cranial nerve palsy, meningitis, and radiculopathy. Blurred vision also can be noted during this stage, secondary to papilledema, optic atrophy, optic or retrobulbar neuritis, or pseudotumor cerebri. Optic nerve disease may be unilateral or bilateral and solitary or associated with other neurologic or neuro-ophthalmologic manifestations. Some evidence exists that children are more predisposed to optic nerve disease than adults.
    • In late stage 2 or stage 3 Lyme disease, most of the severe ocular manifestations of the disease are seen. These include episcleritis, symblepharon, keratitis, iritis, posterior or intermediate uveitis, pars planitis, vitreitis, chorioretinitis, exudative retinal detachment, retinal pigment epithelial detachment, cystoid macular edema, branch artery occlusion, retinal vasculitis, orbital myositis, and cranial nerve palsies. Of this group, keratitis, vitreitis, and pars planitis are the most common. The keratitis usually is a bilateral, patchy, nummular stromal keratitis. Posterior segment inflammatory disease generally presents as a bilateral pars planitis associated with granulomatous iritis and vitreitis. Many of these patients also have granulomatous keratic precipitates and posterior synechiae.

Causes

Lyme disease is caused by the spirochete B burgdorferi.

More on Lyme Disease

Overview: Lyme Disease
Differential Diagnoses & Workup: Lyme Disease
Treatment & Medication: Lyme Disease
Follow-up: Lyme Disease
References

References

  1. Berglöff J, Gasser R, Feigl B. Ophthalmic manifestations in Lyme borreliosis. A review. J Neuroophthalmol. Mar 1994;14(1):15-20. [Medline].

  2. Johnson BJ, Robbins KE, Bailey RE, et al. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis. Aug 1996;174(2):346-53. [Medline].

  3. Karma A, Seppala I, Mikkila H, et al. Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J Ophthalmol. Feb 1995;119(2):127-35. [Medline].

  4. Klig JE. Ophthalmologic complications of systemic disease. Emerg Med Clin North Am. Feb 2008;26(1):217-31, viii. [Medline].

  5. Lesser RL. Ocular manifestations of Lyme disease. Am J Med. Apr 24 1995;98(4A):60S-62S. [Medline].

  6. Lesser RL, Kornmehl EW, Pachner AR, et al. Neuro-ophthalmologic manifestations of Lyme disease. Ophthalmology. Jun 1990;97(6):699-706. [Medline].

  7. Magnarelli LA. Current status of laboratory diagnosis for Lyme disease. Am J Med. Apr 24 1995;98(4A):10S-12S; discussion 12S-14S. [Medline].

  8. Mikkila HO, Seppala IJT, Viljanen MK, et al. The expanding clinical spectrum of ocular Lyme borreliosis. Ophthalmology. Mar 2000;107(3):581-7. [Medline].

  9. Nadelman RB, Wormser GP. A clinical approach to Lyme disease. Mt Sinai J Med. May 1990;57(3):144-56. [Medline].

  10. Rothermel H, Hedges TR 3rd, Steere AC. Optic neuropathy in children with Lyme disease. Pediatrics. Aug 2001;108(2):477-81. [Medline].

  11. Steere AC. Lyme disease. N Engl J Med. Aug 31 1989;321(9):586-96. [Medline].

  12. Steere AC. Lyme disease. N Engl J Med. Jul 12 2001;345(2):115-25. [Medline].

  13. Steere AC, Sikand VK. The presenting manifestations of Lyme disease and the outcomes of treatment. N Engl J Med. Jun 12 2003;348(24):2472-4. [Medline].

  14. Winward KE, Smith JL, Culbertson WW, et al. Ocular Lyme borreliosis. Am J Ophthalmol. Dec 15 1989;108(6):651-7. [Medline].

  15. Wormser GP. Prospects for a vaccine to prevent Lyme disease in humans. Clin Infect Dis. Nov 1995;21(5):1267-74. [Medline].

Further Reading

Keywords

Lyme disease, borreliosis, Lyme borreliosis, ticks, tick bite, tick-borne disease, tick-borne illness, infection, Borrelia burgdorferi, B burgdorferi, ocular Lyme disease, Lyme uveitis, arthropod-related disease, spirochetal disorder, ocular manifestations of Lyme disease

Contributor Information and Disclosures

Author

Gerald W Zaidman, MD, Professor of Clinical Ophthalmology, New York Medical College; Chief of Cornea Service, Acting Director, Department of Ophthalmology, Westchester Medical Center
Gerald W Zaidman, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, American Medical Association, American Society of Cataract and Refractive Surgery, American Uveitis Society, Association for Research in Vision and Ophthalmology, Medical Society of the State of New York, Medical Society of Virginia, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Medical Editor

Kilbourn Gordon III, MD, FACEP, Urgent Care Physician
Kilbourn Gordon III, MD, FACEP is a member of the following medical societies: American Academy of Ophthalmology and Wilderness Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

R Christopher Walton, MD, Professor, Director of Uveitis and Ocular Inflammatory Diseases Service, Assistant Department of Ophthalmology, Assistant Dean for Graduate Medical Education and Continuing Education, University of Tennessee College of Medicine; Consulting Staff, Regional Medical Center, Memphis Veterans Affairs Medical Center, St Jude Children's Research Hospital
R Christopher Walton, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Healthcare Executives, American Uveitis Society, Association for Research in Vision and Ophthalmology, and Retina Society
Disclosure: Nothing to disclose.

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.